Teva Pharmaceutical Industries Stock Forecast

Buy or Hold candidate since Jul 30, 2026 Loss -0.14%

The Teva Pharmaceutical Industries Limited stock price gained 1.58% on the last trading day (Friday, 7th Aug 2026), rising from $34.81 to $35.36. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.58% from a day low at $34.87 to a day high of $35.77. The price has risen in 7 of the last 10 days and is up by 14.77% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 140 thousand more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $151.05 million.

The stockhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $35.21, a level that may pose a second chance to hit a runner. According to fan-theory $40.67 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

TEVA Signals & Forecast

The Teva Pharmaceutical Industries Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $34.89 and $33.10. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 30, 2026, and so far it has fallen -0.141%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Teva Pharmaceutical Industries Limited stock

Teva Pharmaceutical Industries Limited finds support from accumulated volume at $35.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.90 between high and low, or 2.58%. For the last week, the stock has had daily average volatility of 2.59%.

Our recommended stop-loss: $34.09 (-3.58%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (TEVA) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Teva Pharmaceutical Industries Limited to open at $35.33, and during the day (based on 14 day Average True Range), to move between $34.79 and $35.93, which gives a possible trading interval of +/-$1.14 (+/-3.27%) up or down from last closing price. If Teva Pharmaceutical Industries Limited takes out the full calculated possible swing range there will be an estimated 3.27% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $35.32 (0.11%) than the resistance at $35.41 (0.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Teva Pharmaceutical Industries Limited stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.046 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $35.33 ( 0.0754%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk